MELANOMA OF UNKNOWN PRIMARY
Clinical trials for MELANOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new MELANOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for MELANOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Melanoma drug combo shows promise before surgery in early trial
Disease control TerminatedThis study tested two drugs, encorafenib and binimetinib, given before surgery to people with stage IIIB-D melanoma that had spread to lymph nodes. The goal was to see if the drugs could shrink or eliminate tumors before they were removed. Only 3 people enrolled before the study …
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Promising combo therapy for brain melanoma halted early
Symptom relief TerminatedThis early-stage trial tested whether adding a device that creates electric fields (NovoTTF-200M) to standard radiation and immunotherapy could safely treat melanoma that has spread to the brain. Only 1 person took part before the study was stopped. The main goal was to check for…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 17, 2026 05:48 UTC